| [1] | Flyg C, Kenne K, Boman HG (1980) Insect pathogenic properties of Serratia marcescens: phage-resistant mutants with a decreased resistance to Cecropia immunity and a decreased virulence to Drosophila. J Gen Microbiol 120: 173–181.
|
| [2] | Hancock REW, Sahl H-G (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551–1557.
|
| [3] | Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389–395.
|
| [4] | Bell G, Gouyon PH (2003) Arming the enemy: the evolution of resistance to self-proteins. Microbiology 149: 1367–1375.
|
| [5] | Perron GG, Zasloff M, Bell G (2006) Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273: 251–256.
|
| [6] | Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84: 5449–5453.
|
| [7] | Ge Y, MacDonald D, Henry MM, Hait HI, Nelson KA, et al. (1999) In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn Microbiol Infect Dis 35: 45–53.
|
| [8] | Habets MGJL, Brockhurst MA (2012) Therapeutic antimicrobial peptides may compromise natural immunity. Biology Letters 8: 416–418.
|
| [9] | Gravesen A, Ramnath M, Rechinger KB, Andersen N, J？nsch L, et al. (2002) High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes. Microbiology 148: 2361–2369.
|
| [10] | Antoniadou AA, Kontopidou FF, Poulakou GG, Koratzanis EE, Galani II, et al. (2007) Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 59: 786–790.
|
| [11] | Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, et al. (1998) Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 177: 1023–1029.
|
| [12] | Proctor RA, Eiff von C, Kahl BC, Becker K, McNamara P, et al. (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4: 295–305.
|
| [13] | Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, et al. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238: 325–332.
|
| [14] | Chromek M, Slamová Z, Bergman P, Kovács L, Podracká L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636–641.
|
| [15] | Bals R, Goldman MJ, Wilson JM (1998) Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun 66: 1225–1232.
|
| [16] | Pasupuleti M, Walse B, Svensson B, Malmsten M, Schmidtchen A (2008) Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry 47: 9057–9070.
|
| [17] | Kawasaki H, Iwamuro S (2008) Potential Roles of Histones in Host Defense as Antimicrobial Agents. Infect Disord Drug Targets 8: 195–205.
|
| [18] | Turner J, Cho Y, Dinh N-N, Waring AJ, Lehrer RI (1998) Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils. Antimicrob Agents Chemother 42: 2206–14.
|
| [19] | Simon JH, Becker WM (1976) A polyethylene glycol/dextran procedure for the isolation of chromatin proteins (histones and nonhistones) from wheat germ. Biochim Biophys Acta 454: 154–171.
|
| [20] | Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640–6645.
|
| [21] | Cherepanov PP, Wackernagel W (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158: 9–14.
|
| [22] | Lind PA, Tobin C, Berg OG, Kurland CG, Andersson DI (2010) Compensatory gene amplification restores fitness after inter-species gene replacements. Mol Microbiol 75: 1078–1089.
|
| [23] | Dykhuizen DE (1990) Experimental studies of natural selection in bacteria. Annu Rev Ecol Syst 21: 373–98.
|
| [24] | Gullberg E, Cao S, Berg OG, Ilb？ck C, Sandegren L, et al. (2011) Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 7: e1002158 doi:10.1371/journal.ppat.1002158.
|
| [25] | Hughes D, Andersson DI (1997) Carbon starvation of Salmonella typhimurium does not cause a general increase of mutation rates. J Bacteriol.
|
| [26] | Lea DE, Coulson CA (1949) The Distribution of the Numbers of Mutants in Bacterial Populations. J Genet 49: 264–285.
|
| [27] | Anderson RC, Yu P-L (2003) Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils. Biochem Biophys Res Commun 312: 1139–1146.
|
| [28] | Frirdich E, Lindner B, Holst O, Whitfield C (2003) Overexpression of the waaZ Gene Leads to Modification of the Structure of the Inner Core Region of Escherichia coli Lipopolysaccharide, Truncation of the Outer Core, and Reduction of the Amount of O Polysaccharide on the Cell Surface. J Bacteriol 185: 1659–71.
|
| [29] | Yethon JA, Heinrichs DE, Monteiro MA, Perry MB, Whitfield C (1998) Involvement of waaY, waaQ, and waaP in the modification of Escherichia coli lipopolysaccharide and their role in the formation of a stable outer membrane. J Biol Chem 273: 26310–26316.
|
| [30] | Raetz CRH, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635–700.
|
| [31] | Frirdich E, Whitfield C (2005) Review: Lipopolysaccharide inner core oligosaccharide structure and outer membrane stability in human pathogens belonging to the Enterobacteriaceae. J of Endotox Res 11: 133–144.
|
| [32] | Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260–271.
|
| [33] | Denamur E, Matic I (2006) Evolution of mutation rates in bacteria. Mol Microbiol 60: 820–827.
|
| [34] | Helander IM, Vaara M, Sukupolvi S, et al. (1989) rfaP mutants of Salmonella typhimurium. Eur J Biochem 185: 541–546.
|
| [35] | Yethon JA, Gunn JS, Ernst RK, Miller SI, Laroche L, et al. (2000) Salmonella enterica serovar typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence In vivo. Infect Immun 68: 4485–4491.
|
| [36] | Roland KL, Martin LE, Esther CR, Spitznagel JK (1993) Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J Bacteriol 175: 4154–4164.
|
| [37] | Gunn JS, Ryan SS, Van Velkinburgh JC, Ernst RK, Miller SI (2000) Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect Immun 68: 6139–6146.
|
| [38] | Nishino K, Hsu F-F, Turk J, Cromie MJ, W？sten MMSM, et al. (2006) Identification of the lipopolysaccharide modifications controlled by the Salmonella PmrA/PmrB system mediating resistance to Fe(III) and Al(III). Mol Microbiol 61: 645–654.
|
| [39] | Gunn JS, Lim KB, Krueger J, Kim K, GUO L, et al. (1998) PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27: 1171–1182.
|
| [40] | Zhou Z, Ribeiro AA, Lin S, Cotter RJ, Miller SI, et al. (2001) Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J Biol Chem 276: 43111–43121.
|
| [41] | Gunn JS (2001) Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotox Res 7: 57–62.
|
| [42] | Miller SI, Kukral AM, Mekalanos JJ (1989) A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci USA 86: 5054–5058.
|
| [43] | Groisman EA (2001) The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol 183: 1835–1842.
|
| [44] | Gunn JS, Miller SI (1996) PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 178: 6857–6864.
|
| [45] | Raetz CRH, Reynolds CM, Trent MS, Bishop RE (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76: 295–329.
|
| [46] | Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, Miller SI (1998) Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides. Cell 95: 189–198.
|
| [47] | Bishop RE (2005) The lipid A palmitoyltransferase PagP: molecular mechanisms and role in bacterial pathogenesis. Mol Microbiol 57: 900–912.
|
| [48] | Gibbons HS (2000) Oxygen Requirement for the Biosynthesis of the S-2-Hydroxymyristate Moiety in Salmonella typhimurium Lipid A. J Biol Chem. 275: 32940–32949.
|
| [49] | Gunn JS, Ernst RK, McCoy AJ, Miller SI (2000) Constitutive mutations of the Salmonella enterica serovar Typhimurium transcriptional virulence regulator phoP. Infect Immun 68: 3758–3762.
|
| [50] | Bishop RE, Gibbons HS, Guina T, Trent MS, Miller SI, et al. (2000) Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J 19: 5071–5080.
|
| [51] | Miller SI, Pulkkinen WS, Selsted ME, Mekalanos JJ (1990) Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun 58: 3706–3710.
|
| [52] | Davidopoulou S, Diza E, Menexes G, Kalfas S (2012) Salivary concentration of the antimicrobial peptide LL-37 in children. Arch Oral Biol 57: 865–869.
|
| [53] | S？rensen O, Cowland JB, Askaa J, Borregaard N (1997) An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206: 53–59.
|
| [54] | Ernst RK, Guina T, Miller SI (2001) Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes and Infection 3: 1327–1334.
|
| [55] | Gunn JS (2008) The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 16: 284–290.
|
| [56] | Cai X, Zhang J, Chen M, Wu Y, Wang X, et al. (2011) The effect of the potential PhoQ histidine kinase inhibitors on Shigella flexneri virulence. PLoS ONE 6: e23100 doi:10.1371/journal.pone.0023100.
|
| [57] | Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB (2004) The Response Regulator PhoP of Yersinia pseudotuberculosis Is Important for Replication in Macrophages and for Virulence. Infect Immun 72: 338–44.
|
| [58] | Gunn JS, Hohmann EL, Miller SI (1996) Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP. J Bacteriol 178: 6369–73.
|
| [59] | Schurek KN, Sampaio JLM, Kiffer CRV, Sinto S, Mendes CMF, et al. (2009) Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 4345–4351.
|
| [60] | Barrow K, Kwon DH (2009) Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 5150–5154.
|
